Asantae Holdings International Inc. Announces Acquisition of the Rights to an Immune System Supplement Formula
January 13 2011 - 7:00AM
Marketwired
Asantae Holdings International Inc. ("Asantae") (TSX-V: JVA) is
pleased to announce that it has acquired the rights to an immune
system supplement formula. Asantae plans to unveil this new product
under the name Asantae Amune Plus™ later this month
.
Amune Plus™ is formulated with two immune system support
ingredients -- Ai/E(10)® and Astragalus. Ai/E(10)® is a whey
extract derived from cow's milk that has been influenced to create
a beneficial and highly focused array of immune communication
molecules. These molecules help your body to build new cells,
modulate immune function and sustain immune system performance.
Astragalus is an herb that has been used for centuries for immune
support and balance.
"Amune Plus™ is a great addition to our product line up because
it addresses a global health issue that is important to most
people, their immunity," says Jeff Jordan, president of Asantae.
"Plus, it brings with it many customers and sales representatives
that have relied on this product for years and are looking to
continue to use it."
The formula was acquired from Health Technology Resources, Inc.
and was previously marketed under the name Biomune OSF Plus® by
Matol.
"Amune Plus is unique in that it not only contains the
proprietary and branded dietary ingredient Ai/E(10)®, which has
been shown to support the structure and function of the immune
system, but it combines it with an herb that has been used for
immunity for centuries," says David Bergsma, President of Health
Technology Resources, Inc. "Asantae now possesses an outstanding
dietary supplement for the modulated support of innate and adaptive
immunity which can create a tremendous opportunity for the
company's growth and support of its mission to help improve health
worldwide."
About Asantae Holdings International
Inc.
Asantae Holdings International Inc. (TSX-V: JVA) is a producer
and marketer of innovative nutritional products through direct and
network marketing channels. The ingredients in Asantae's products
have been shown to reduce chronic low-grade inflammation and
oxidative stress which, according to scientific and medical
research, are the underlying conditions for most modern epidemic
diseases (diabetes, heart disease, obesity, stroke, etc.).
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the content of this
press release. This press release contains forward-looking
statements that include statements as to the potential of our
product, such as "[Amune Plus] brings with it many customers and
sales representatives that have relied on this product for years
and are looking to continue to use it" and "Asantae now possesses
an outstanding dietary supplement for the modulated support of
innate and adaptive immunity which can create a tremendous
opportunity for the company's growth and support of its mission to
help improve health worldwide."
Certain risks and uncertainties such establishing and
maintaining affiliate relationships, expanding our business in
existing markets and international markets, gaining market
acceptance of new products, adverse or negative publicity, limited
operating history, reliance on a limited number of products,
competition from companies selling similar products, product
liability claims and recalls, reliance on outside manufacturing and
suppliers, protecting intellectual property, reliance on key
personnel, and government regulations and global economic
conditions could cause Asantae's actual results to differ
materially from those in the forward-looking statements.
For further information Keyvan Taheri CEO Phone:
480-278-8700 Fax: 480-383-6147
Avidus Management Group, Inc. (TSXV:JVA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Avidus Management Group, Inc. (TSXV:JVA)
Historical Stock Chart
From Oct 2023 to Oct 2024